Partial splenic embolization with embosphere microspheres (700-900 µm) for the treatment of hypersplenism: comparison of selective superior splenic artery embolization and inferior splenic artery embolization

脾动脉 栓塞 医学 放射科 优势比 脾脏 置信区间 外科 内科学
作者
Chao Ma,Yan Wang,Heng Zhang,Feng Duan,Maoqiang Wang
出处
期刊:Minimally Invasive Therapy & Allied Technologies [Informa]
卷期号:: 1-10
标识
DOI:10.1080/13645706.2024.2339917
摘要

Objective: To compare clinical outcomes of superior versus inferior splenic artery embolization in partial splenic embolization (PSE) and identify predictors of major complications. Material and methods: This retrospective case-control study included 73 patients who underwent PSE between May 2005 and April 2021. They were divided into two groups: the superior and middle splenic artery embolization group (Group A, n = 37) and the inferior and middle splenic artery embolization group (Group B, n = 36). Outcome differences and major complications between the groups were assessed. Logistic regression was used to analyze potential predictors of major complications, and the optimal cutoff value for splenic embolization rates was determined using the Youden index. Results: There were no significant differences in laboratory and radiological outcomes between the two groups. Group A had a significantly lower incidence of major complications than Group B (p = 0.049), a lower Visual Analog Scale (VAS) score for pain (p = 0.036), and a shorter hospital stay (p = 0.022). Independent risk factors for major complications included inferior and middle splenic artery embolization (odds ratio [OR] = 3.672; 95% confidence interval [CI] = 1.028-13.120; p = 0.045) and a higher spleen embolization rate (OR = 1.108; 95% CI = 1.003-1.224; p = 0.044). The optimal cutoff for spleen embolization rate to predict major complications was 59.93% (sensitivity 77.8%, specificity 63.6%). Conclusion: Using 500-700 µm microspheres for PSE, targeting the middle and superior splenic artery yields similar effects to targeting the middle and inferior artery, but results in lower rates of major complications and shorter hospital stays. To effectively minimize the risk of major complications, the embolization rate should be kept below 59.93%, regardless of the target vessel.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
最棒哒发布了新的文献求助10
刚刚
1秒前
情怀应助Tutu采纳,获得10
1秒前
粗心的飞槐完成签到 ,获得积分10
1秒前
Singularity发布了新的文献求助10
1秒前
2秒前
文艺梦容完成签到,获得积分10
2秒前
xia发布了新的文献求助10
2秒前
ww完成签到,获得积分10
4秒前
沙漠西瓜皮完成签到 ,获得积分10
7秒前
liu欣慰发布了新的文献求助10
8秒前
文艺梦容发布了新的文献求助10
8秒前
9秒前
不配.应助你的大碗采纳,获得10
9秒前
11秒前
11秒前
xia完成签到,获得积分10
12秒前
酷酷的安柏完成签到 ,获得积分10
12秒前
成就忻发布了新的文献求助10
13秒前
MAKEYF完成签到 ,获得积分10
16秒前
碎碎念完成签到 ,获得积分10
16秒前
17秒前
17秒前
沉淀发布了新的文献求助10
17秒前
奥米希完成签到,获得积分10
18秒前
绝尘发布了新的文献求助10
21秒前
慕青应助我是魔王采纳,获得10
21秒前
yukang完成签到,获得积分10
21秒前
jiesenya完成签到,获得积分10
24秒前
小莫完成签到 ,获得积分10
25秒前
Anna完成签到,获得积分10
29秒前
大模型应助沉淀采纳,获得10
29秒前
30秒前
哈哈哈的一笑完成签到,获得积分10
31秒前
成就忻完成签到,获得积分20
31秒前
32秒前
冬卉完成签到,获得积分20
32秒前
桶治世界完成签到,获得积分10
34秒前
38秒前
ely完成签到,获得积分20
38秒前
高分求助中
Medicina di laboratorio. Logica e patologia clinica 600
Sarcolestes leedsi Lydekker, an ankylosaurian dinosaur from the Middle Jurassic of England 500
《关于整治突出dupin问题的实施意见》(厅字〔2019〕52号) 500
Language injustice and social equity in EMI policies in China 500
mTOR signalling in RPGR-associated Retinitis Pigmentosa 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版 401
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3213946
求助须知:如何正确求助?哪些是违规求助? 2862516
关于积分的说明 8134144
捐赠科研通 2528729
什么是DOI,文献DOI怎么找? 1362847
科研通“疑难数据库(出版商)”最低求助积分说明 643729
邀请新用户注册赠送积分活动 616041